<DOC>
	<DOCNO>NCT02849769</DOCNO>
	<brief_summary>Following product approval , confirmation MR Conditional Tachyarrhythmia Therapy Systems sense detection performance post MRI exposure obtain actively monitor de-identified device data obtain Medtronic CareLink® Network .</brief_summary>
	<brief_title>Magnetic Resonance ( MR ) Conditional Tachyarrhythmia Therapy Products Post-approval Study</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<criteria>MR conditional tachyarrhythmia therapy system enrol Medtronic CareLink® Network ( CL ) use prospectively assess spontaneous Ventricular Fibrillation ( VF ) episode detection follow MRI exposure .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>